This week I was alerted to an interesting development with potentially great import for diabetics and uses a so-called "slow release" starch (SRS) to help treat hypoglycaemia. This is being developed by a company in Scotland based on university research programs.
The company is called GlycoLogic which has programs to develop various innovative drug delivery systems based on carbohydrates.
Glycologic has developed a starch derivative which they say is digested slowly in the gastrointestinal tract releasing glucose over a longer time than the more usual starches so it can prevent hypoglycaemia. Extensive clinical trials have been conducted and concluded for metabolic disorders, liver disease, sports nutrition and diabetes.
Work continues with respect to type I and type II diabetes and other clinical applications of the technology.
http://www.glycologic.co.uk/welcome.asp
A technical paper on the subject is "Use of slow release starch (SRS) to treat hypoglycaemia in type 1 diabetics" and the abstract can be found here:
http://strathprints.strath.ac.uk/26053/
This research paper says that the SRS may be used as a cost effective therapy to avoid hypoglycaemia in patients with type-1 diabetes and reports for the first time the use of a physically modified waxy maize starch (SRS) to prevent/limit the incidence of nocturnal hypoglycaemia.
Could not find where you can buy this stuff though... I wonder what it tastes like, a bit better than met I hope. 8)
Thanks Indy51!
The company is called GlycoLogic which has programs to develop various innovative drug delivery systems based on carbohydrates.
Glycologic has developed a starch derivative which they say is digested slowly in the gastrointestinal tract releasing glucose over a longer time than the more usual starches so it can prevent hypoglycaemia. Extensive clinical trials have been conducted and concluded for metabolic disorders, liver disease, sports nutrition and diabetes.
Work continues with respect to type I and type II diabetes and other clinical applications of the technology.
http://www.glycologic.co.uk/welcome.asp
A technical paper on the subject is "Use of slow release starch (SRS) to treat hypoglycaemia in type 1 diabetics" and the abstract can be found here:
http://strathprints.strath.ac.uk/26053/
This research paper says that the SRS may be used as a cost effective therapy to avoid hypoglycaemia in patients with type-1 diabetes and reports for the first time the use of a physically modified waxy maize starch (SRS) to prevent/limit the incidence of nocturnal hypoglycaemia.
Could not find where you can buy this stuff though... I wonder what it tastes like, a bit better than met I hope. 8)
Thanks Indy51!
